EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Biological biomarkers of oral cancer

Allan Radaic, Pachiyappan Kamarajan, Alex Cho, Sandy Wang, Guo-Chin Hung, Fereshteh Najarzadegan, David T Wong, Hung Ton-That, Cun-Yu Wang, Yvonne L Kapila

Periodontology 2000 · 2024-10 · 96 (1) · 250-280

DOI: 10.1111/prd.12542 ↗

At a glance

Übersichtsarbeit in Periodontology 2000, published online on 2023-12-10. Written by Allan Radaic and 9 co-authors. Institution: School of Dentistry, University of California, Los Angeles (UCLA), Los Angeles, California, USA. Major MEDLINE topics: Mouth Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell. Cited 95 times so far (Crossref); 246 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCI NIH HHS, NIH HHS, National Institutes of Health.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The oral squamous cell carcinoma (OSCC) 5 year survival rate of 41% has marginally improved in the last few years, with less than a 1% improvement per year from 2005 to 2017, with higher survival rates when detected at early stages. Based on histopathological grading of oral dysplasia, it is estimated that severe dysplasia has a malignant transformation rate of 7%–50%. Despite these numbers, oral dysplasia grading does not reliably predict its clinical behavior. Thus, more accurate markers predicting oral dysplasia progression to cancer would enable better targeting of these lesions for closer follow‐up, especially in the early stages of the disease. In this context, molecular biomarkers derived from genetics, proteins, and metabolites play key roles in clinical oncology. These molecular signatures can help predict the likelihood of OSCC development and/or progression and have the potential to detect the disease at an early stage and, support treatment decision‐making and predict treatment responsiveness. Also, identifying reliable biomarkers for OSCC detection that can be obtained non‐invasively would enhance management of OSCC. This review will discuss biomarkers for OSCC that have emerged from different biological areas, including genomics, transcriptomics, proteomics, metabolomics, immunomics, and microbiomics.

Subjects

MeSH terms (MEDLINE)

Mouth NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellHumansProteomicsMetabolomicsGenomicsDisease Progression

Author keywords

OPMDOSCCbiomarkersgenomicshuman papilloma virus (HPV)immunomicsmetabolomicsmicrobiomicsoral potentially malignant disordersoral squamous cell carcinomaproteomics

Substances

Biomarkers, Tumor

Authors and institutions

  • School of Dentistry, University of California, Los Angeles (UCLA), Los Angeles, California, USA.

Funding

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Radaic, A., Kamarajan, P., Cho, A., Wang, S., Hung, G. C., Najarzadegan, F., Wong, D. T., Ton-That, H., Wang, C. Y., & Kapila, Y. L. (2024). Biological biomarkers of oral cancer. Periodontology 2000, 96(1), 250-280. https://doi.org/10.1111/prd.12542

Vancouver

Radaic A, Kamarajan P, Cho A, Wang S, Hung GC, Najarzadegan F, et al. Biological biomarkers of oral cancer. Periodontology 2000. 2024;96(1):250-280. doi:10.1111/prd.12542

BibTeX
@article{Radaic2024,
  author = {Radaic, Allan and Kamarajan, Pachiyappan and Cho, Alex and Wang, Sandy and Hung, Guo-Chin and Najarzadegan, Fereshteh and Wong, David T and Ton-That, Hung and Wang, Cun-Yu and Kapila, Yvonne L},
  title = {Biological biomarkers of oral cancer},
  journal = {Periodontology 2000},
  year = {2024},
  volume = {96},
  number = {1},
  pages = {250--280},
  doi = {10.1111/prd.12542}
}
Start for free →